U.S. Fears Overblown, Japan Says

TOKYO—American fears that Japan is coordinating a national effort to achieve world supremacy in high-temperature superconductivity R&D are exaggerated, say Japanese scientists and officials, who point out that the government lacks the money and clout to orchestrate such a campaign. "Too many people in the U.S. are overestimating our abilities," said Masatoshi Urashima, director for development of advanced industries in the Agency for. Indus trial Science and Technology under MITI (the Min

Written byJohn Boyd
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

"Too many people in the U.S. are overestimating our abilities," said Masatoshi Urashima, director for development of advanced industries in the Agency for. Indus trial Science and Technology under MITI (the Ministry of International Trade and Industry). A study group set up by MITI that includes industry, university and national laboratory representatives met for the first time April 14, he said, "to evaluate the recent breakthroughs and discuss what we should do." No date for a second meeting has been set, he added.

Shoji Tanaka, a Tokyo University professor who is a leading figure in superconductivity research here, said he is pessimistic about Japan's ability to take the decisive cooperative action he urges.

"One problem is money," he said. "Our fiscal year begins in April and our budget was fixed last December, so there simply aren't funds to do anything on a major scale. Bureaucrats can't keep pace with the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies